(4-traders.com) DUBLIN, Aug. 31, 2015 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that it has successfully completed the acquisition of Naurex Inc., a clinical-stage biopharmaceutical company developing transformative therapies for challenging disorders of the central nervous system,...http://www.4-traders.com/ALLERGAN-INC-11564/news/Allergan--Successfully-Completes-Naurex-Acquisition-21017321/